日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).

发现帕拉塞斯特兰(OP-1250),一种强效且口服生物利用度高的完全雌激素受体拮抗剂(CERAN)和选择性雌激素受体降解剂(SERD)

Ng Raymond A, Barratt Susanna, Parisian Alison, Palanisamy Gopinath S, Phukan Samiron, Sun Richard, Robello Brandon, Peña Guadalupe, Sapugay Judevin, Yeghikyan David, Wang Chenbo, Satish Kher Samir, Thangathirupathy Srinivasan, Millikin Robert, Yu Guijun, Watanabe Teruki, Zhou Fei, Rich Brian, Duncan Alexis, Andersen Samuel E, Chawla Reena, Zak David R, Heerding Dirk A, Hearn Brian R, Greene Geoffrey, Harmon Cyrus L, Hodges-Gallagher Leslie, Kushner Peter J, Fanning Sean W, Myles David C

Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination

Palazestrant (OP-1250) 是一种完全雌激素受体拮抗剂,可作为单一疗法和联合疗法抑制野生型和突变型 ER 阳性乳腺癌模型

Alison D Parisian, Susanna A Barratt, Leslie Hodges-Gallagher, Fabian E Ortega, Guadalupe Peña, Judevin Sapugay, Brandon Robello, Richard Sun, David Kulp, Gopinath S Palanisamy, David C Myles, Peter J Kushner, Cyrus L Harmon

Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101

通过靶向RNP的抗体ATRC-101动员先天性和适应性抗肿瘤免疫反应

Scholz, Alexander; DeFalco, Jeff; Leung, Yvonne; Aydin, Iraz T; Czupalla, Cathrin J; Cao, Wei; Santos, Daniel; Vad, Nikhil; Lippow, Shaun M; Baia, Gilson; Harbell, Michael; Sapugay, Judevin; Zhang, Danhui; Wu, Dai-Chen; Wechsler, Erin; Ye, Anne Z; Wu, Jenny W; Peng, Xiao; Vivian, John; Kaplan, Hargita; Collins, Rodney; Nguyen, Ngan; Whidden, Mark; Kim, Dongkyoon; Millward, Carl; Benjamin, Jonathan; Greenberg, Norman M; Serafini, Tito A; Emerling, Daniel E; Steinman, Lawrence; Robinson, William H; Manning-Bog, Amy